In the only study considering all three factors (estrous cycle, orexin system, and cocaine use disorder), the OX1R-selective antagonist SB-334867 was shown to attenuate cocaine-induced hyperlocomotion in both sexes of rats while being detected at higher plasma concentrations during the estrus phase in females (Zhou et al. 2012). Here, HCRTR1 is linked to cocaine use disorder.